Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug launch
Pharma
As RevMed preps for ‘historic’ cancer launch, questions linger
An inexperienced RevMed is now responsible for launching the most hotly anticipated cancer drug in years.
Darren Incorvaia
Aug 27, 2026 11:27am
Hansa eyes US listing ahead of FDA verdict on Idefirix
Aug 24, 2026 2:45pm
Xspray's Dasynoc knocked back by FDA over production once again
Aug 20, 2026 2:50pm
Ultragenyx, after FDA speed bump, lands 1st gene therapy nod
Aug 19, 2026 10:33pm
Celcuity needs facility sign-off to kick off its market launch
Aug 18, 2026 9:26am
Obesity not a winner-takes-all game, Novo CEO says: Reuters
Aug 13, 2026 11:33am
